Breast MRI as a Screening Tool: The Appropriate Role

Author: Huong T. Le-Petross MD, FRCPS1
View More View Less
  • 1 From The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Magnetic resonance imaging (MRI) can detect breast cancer that is occult on mammography or ultrasound. However, although the high sensitivity of this imaging modality is desirable, its lower specificity, higher cost, variable technique and interpretation among institutions, exclusion criteria, and unproven effect on survival rate make it a less desirable screening test for the general population. Several studies have shown that using more than one imaging tool, such as MRI and mammography, increases cancer yield in high-risk patients, such as those with inherited BRCA1 and BRCA2 mutations. Recent studies show improved specificity of MRI, likely related to advances in technique and the development of interpretive guidelines.

Correspondence: Huong T. Le-Petross, MD, FRCPS, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009. E-mail: huong.le-petross@di.mdacc.tmc.edu
  • 1.

    Ries LAG, Eisner MP, Kosary CL et al.. SEER cancer statistics review, 1975–2002. Bethesda: National Cancer Institute, 2004.

  • 2.

    Breast Cancer Facts and Figures 2005–2006. Atlanta: American Cancer Society, 2005.

  • 3.

    Verhoog LC, Brekelmans CT, Seynaeve C et al.. Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;351:316321.

    • Search Google Scholar
    • Export Citation
  • 4.

    Cancer Research Campaign (CRC) Genetic Epidemiology Unit, Strangeways Research Laboratory, Cambridge, U.K. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:13101316.

    • Search Google Scholar
    • Export Citation
  • 5.

    Ford D, Easton DF, Bishop DT et al.. Risks of cancer in BRCA1-mutation carriers. The Breast Cancer Linkage Consortium. Lancet 1994;19;343:692695.

  • 6.

    Kuhl CK, Kuhn W, Schild H. Management of women at high risk for breast cancer: New imaging beyond mammography. Breast 2005;14:480486.

  • 7.

    Mitchell G, Antoniou AC, Warren R. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 2006;66:18661872.

    • Search Google Scholar
    • Export Citation
  • 8.

    Lehman CD, Blume JD, Weatherall P et al.. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103:18981905.

    • Search Google Scholar
    • Export Citation
  • 9.

    Morris EA, Liberman L, Ballon DJ et al.. MRI of occult breast carcinoma in a high-risk population. Am J Roentgenol 2003;181:519525.

  • 10.

    Lehman CD, Blume JD, Thickman D et al.. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005;92:915.

    • Search Google Scholar
    • Export Citation
  • 11.

    Warner E, Plewes DB, Shumak RS et al.. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:35243531.

    • Search Google Scholar
    • Export Citation
  • 12.

    Stoutjesdijk MJ, Boetes C, Jager GJ et al.. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;18;93:10951102.

    • Search Google Scholar
    • Export Citation
  • 13.

    Kriege M, Cecile TM, Brekelmans MD et al.. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427437.

    • Search Google Scholar
    • Export Citation
  • 14.

    Warner E, Plewes DB, Hill KA et al.. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:13171325.

    • Search Google Scholar
    • Export Citation
  • 15.

    Kuhl CK, Schrading S, Leutner CC et al.. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:84698476.

    • Search Google Scholar
    • Export Citation
  • 16.

    Liberman L. The high risk patient and magnetic resonance imaging. In: Morris EA, Liberman L, eds. Breast MRI Diagnosis and Intervention. New York: Springer, 2005:184199.

    • Search Google Scholar
    • Export Citation
  • 17.

    Lee CH, Weinreb JC. The use of magnetic resonance imaging in breast cancer screening. J Am Coll Radiol 2004;1:176182.

  • 18.

    Morris EA. Screening for breast cancer with MRI. Semin Ultrasound, CT MR 2003;24:4554.

  • 19.

    Komenaka IK, Ditkoff BA, Joseph KA et al.. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100:20792083.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 85 30 1
PDF Downloads 55 21 0
EPUB Downloads 0 0 0